14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CABA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Cabaletta Bio, Inc.
(Updated on Apr 24, 2024)

Sell candidate since Apr 09, 2024 Loss -31.14% PDF

The Cabaletta Bio, Inc. stock price fell by -2.70% on the last day (Wednesday, 24th Apr 2024) from $13.32 to $12.96. During the last trading day the stock fluctuated 5.97% from a day low at $12.90 to a day high of $13.67. The price has fallen in 7 of the last 10 days and is down by -27.44% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -7 thousand shares and in total, 738 thousand shares were bought and sold for approximately $9.57 million.

The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($13.85) are considered to be a "second chance" to get out. According to the fan-theory $10.65 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CABA Signals & Forecast

There are few to no technical positive signals at the moment. The Cabaletta Bio, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $14.05 and $17.44. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 09, 2024, and so far it has fallen -31.14%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Cabaletta Bio, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.770 between high and low, or 5.97%. For the last week, the stock has had daily average volatility of 6.97%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CABA) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Cabaletta Bio, Inc. to open at $13.18, and during the day (based on 14 day Average True Range), to move between $11.86 and $14.06, which gives a possible trading interval of +/-$1.10 (+/-8.53%) up or down from last closing price. If Cabaletta Bio, Inc. takes out the full calculated possible swing range there will be an estimated 17.05% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $13.32, some $0.360 (2.78%) from the current price of $12.96, our system finds the risk reward not very attractive.

Is Cabaletta Bio, Inc. stock A Buy?

Cabaletta Bio, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.716 Sell Candidate Unchanged

Predicted Opening Price for Cabaletta Bio, Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$13.18 ( 1.67%) $12.96

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CABA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.95 7.61 %
R2 13.65 5.34 %
R1 13.47 3.94 %
Current price: 12.96
Support S1 12.88 -0.598 %
S2 12.70 -2.00 %
S3 12.41 -4.27 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 16.11 24.31 %
R2 13.34 2.93 %
R1 13.32 2.78 %
Current price 12.96
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Cabaletta Bio, Inc. Stock and on which exchange is it traded?
The symbol for Cabaletta Bio, Inc. is CABA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cabaletta Bio, Inc. Stock?
Cabaletta Bio, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Cabaletta Bio, Inc. Stock?
Cabaletta Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cabaletta Bio, Inc. Stock.

What's the current price of Cabaletta Bio, Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Cabaletta Bio, Inc. (CABA) share was $12.96.

What is the 52-week high and low for Cabaletta Bio, Inc. Stock?
The 52-week high for Cabaletta Bio, Inc. Stock is $26.35 and the 52-week low is $7.69.

What is the market capitalization of Cabaletta Bio, Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Cabaletta Bio, Inc. is 625.211M.

When is the next earnings date for Cabaletta Bio, Inc.?
The upcoming earnings date for Cabaletta Bio, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Cabaletta Bio, Inc.

Cabaletta Bio. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART,... CABA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT